Concepedia

Author

Jorge Aparicio

Hospital Universitari i Politècnic La FeORCID

Also Known As

Aparicio Jorge, Aparicio, J., Aparicio, Jorge, D. Almenar, J APARICIO, J Aparicio, J. Aparicio, Joaquín Llacer Aparicio, Jorge Aparicio, José Alfonso Flores Aparicio

280

Publications

9.3K

Citations

37

H-Index

68

Concepts

All Affiliations

Hospital Universitari i Politècnic La FeHospital de Sant PauHospital Universitario La PazFundación Instituto Valenciano de OncologíaHospital Arnau de Vilanova
JA

About

Jorge Aparicio is an author at Hospital Universitari i Politècnic La Fe specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

52

4.5K

2

Health Sciences

10

13

778

3

Public Health

3

3

53

4

Engineering

1

1

31

5

Biostatistics

1

1

31

Jorge Aparicio

×

93

Publications

8.7K

Citations

35

H-Index

YearCitations

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

Carsten Bokemeyer, Igor Bondarenko, Anatoly Makhson,

Journal of Clinical Oncology

2008

1.6K

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten,

The Lancet Oncology

2020

1.5K

Phase II, Randomized Study of Concomitant Chemoradiotherapy Followed by Surgery and Adjuvant Capecitabine Plus Oxaliplatin (CAPOX) Compared With Induction CAPOX Followed by Concomitant Chemoradiotherapy and Surgery in Magnetic Resonance Imaging–Defined, Locally Advanced Rectal Cancer: Grupo Cáncer de Recto 3 Study

Carlos Fernández-Martos, Carles Pericay, Jorge Aparicio,

Journal of Clinical Oncology

2010

428

Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial

Carlos Fernández-Martos, Xabier García‐Albéniz, Carles Pericay,

Annals of Oncology

2015

352

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

J. Beyer, Peter Albers, Renske Altena,

Annals of Oncology

2012

320

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

Friedemann Honecker, Jorge Aparicio, Daniel M. Berney,

Annals of Oncology

2018

319

Viable Malignant Cells After Primary Chemotherapy for Disseminated Nonseminomatous Germ Cell Tumors: Prognostic Factors and Role of Postsurgery Chemotherapy—Results From an International Study Group

Karim Fizazi, Sergei Tjulandin, Roberto Salvioni,

Journal of Clinical Oncology

2001

279

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial

Eduardo Díaz‐Rubio, Josep Tabernero, Auxiliadora Gómez‐España,

Journal of Clinical Oncology

2007

267

Risk-Adapted Management for Patients With Clinical Stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study

Jorge Aparicio, J.R. Germà, Xavier García del Muro,

Journal of Clinical Oncology

2005

231

Prognostic factors and outcomes for osteosarcoma: An international collaboration

Emilios E. Pakos, Andreas Nearchou, R. J. Grimer,

European Journal of Cancer

2009

194

Page 1